Cancer nanomedicines: Closing the translational gap

Alberto Gabizon, Michelle Bradbury, Uma Prabhakar, William Zamboni, Steven Libutti, Piotr Grodzinski

Research output: Contribution to journalArticle

37 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2175-2176
Number of pages2
JournalThe Lancet
Volume384
Issue number9961
DOIs
StatePublished - Dec 27 2014

Fingerprint

Drug Legislation
Nanomedicine
Precision Medicine
Preclinical Drug Evaluations
Drug Delivery Systems
Antineoplastic Agents
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gabizon, A., Bradbury, M., Prabhakar, U., Zamboni, W., Libutti, S., & Grodzinski, P. (2014). Cancer nanomedicines: Closing the translational gap. The Lancet, 384(9961), 2175-2176. https://doi.org/10.1016/S0140-6736(14)61457-4

Cancer nanomedicines : Closing the translational gap. / Gabizon, Alberto; Bradbury, Michelle; Prabhakar, Uma; Zamboni, William; Libutti, Steven; Grodzinski, Piotr.

In: The Lancet, Vol. 384, No. 9961, 27.12.2014, p. 2175-2176.

Research output: Contribution to journalArticle

Gabizon, A, Bradbury, M, Prabhakar, U, Zamboni, W, Libutti, S & Grodzinski, P 2014, 'Cancer nanomedicines: Closing the translational gap', The Lancet, vol. 384, no. 9961, pp. 2175-2176. https://doi.org/10.1016/S0140-6736(14)61457-4
Gabizon A, Bradbury M, Prabhakar U, Zamboni W, Libutti S, Grodzinski P. Cancer nanomedicines: Closing the translational gap. The Lancet. 2014 Dec 27;384(9961):2175-2176. https://doi.org/10.1016/S0140-6736(14)61457-4
Gabizon, Alberto ; Bradbury, Michelle ; Prabhakar, Uma ; Zamboni, William ; Libutti, Steven ; Grodzinski, Piotr. / Cancer nanomedicines : Closing the translational gap. In: The Lancet. 2014 ; Vol. 384, No. 9961. pp. 2175-2176.
@article{b2839df1fec142f390529f8763a1eb1d,
title = "Cancer nanomedicines: Closing the translational gap",
author = "Alberto Gabizon and Michelle Bradbury and Uma Prabhakar and William Zamboni and Steven Libutti and Piotr Grodzinski",
year = "2014",
month = "12",
day = "27",
doi = "10.1016/S0140-6736(14)61457-4",
language = "English (US)",
volume = "384",
pages = "2175--2176",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9961",

}

TY - JOUR

T1 - Cancer nanomedicines

T2 - Closing the translational gap

AU - Gabizon, Alberto

AU - Bradbury, Michelle

AU - Prabhakar, Uma

AU - Zamboni, William

AU - Libutti, Steven

AU - Grodzinski, Piotr

PY - 2014/12/27

Y1 - 2014/12/27

UR - http://www.scopus.com/inward/record.url?scp=84919361003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919361003&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(14)61457-4

DO - 10.1016/S0140-6736(14)61457-4

M3 - Article

C2 - 25625382

AN - SCOPUS:84919361003

VL - 384

SP - 2175

EP - 2176

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9961

ER -